Development and Standardization of a Polyherbal Formulation for the Management of Diabetes
Journal of Pharma Insights and Research · 05.04.2026 · 4 (2) · 016-023
DOI: 10.69613/a94s4w59 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharma Insights and Research, online erschienen am 05.04.2026. Verfasst von Divya Gopiratnam T und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus is a chronic metabolic syndrome characterized by persistent hyperglycemia, which frequently leads to debilitating systemic complications. While conventional oral hypoglycemic agents are effective, their long-term utilization is often constrained by adverse metabolic effects and the high cost of treatment. This research presents the systematic formulation, standardization, and pharmacological evaluation of a polyherbal powder designed for synergistic glycemic management. The formulation incorporates a specific ratio of Gymnema sylvestre (30g), Momordica charantia (25g), Trigonella foenum-graecum (20g), Ocimum sanctum (15g), and Azadirachta indica (10g). Systematic processing through controlled drying and comminution ensured a uniform distribution of bioactive phytochemicals. Physicochemical assessment demonstrated a moisture content of 5.8% and a total ash value of 6.2%, indicating high purity. The in vivo antidiabetic potential was evaluated in Streptozotocin (STZ)-induced diabetic Wistar rats. Oral administration of the polyherbal formulation at doses of 200 mg/kg and 400 mg/kg significantly (p < 0.01) reduced fasting blood glucose levels from 285.4 ± 10.2 mg/dL to 115.6 ± 6.8 mg/dL by the 21st day of treatment, comparable to the standard drug Glibenclamide (105.2 ± 4.5 mg/dL). Micromeritic profiling further confirmed excellent flow characteristics (Carr’s index: 12.7%) suitable for pharmaceutical scale-up. These results provide scientific validation for the formulation's safety and potent antihyperglycemic efficacy, supporting its use as a standardized phytotherapeutic agent
Zitieren
APA
T, D. G., Ch, N., P, D. S., K, S. N. R., & V, N. S. B. S. L. (2026). Development and Standardization of a Polyherbal Formulation for the Management of Diabetes. Journal of Pharma Insights and Research, 4(2), 016-023. https://doi.org/10.69613/a94s4w59
Vancouver
T DG, Ch N, P DS, K SNR, V NSBSL. Development and Standardization of a Polyherbal Formulation for the Management of Diabetes. Journal of Pharma Insights and Research. 2026;4(2):016-023. doi:10.69613/a94s4w59
BibTeX
@article{T2026,
author = {T, Divya Gopiratnam and Ch, Nehambika and P, Devi Sri and K, Sai Naga Renuka and V, Naga Sai Bhagya Sri Lekha},
title = {Development and Standardization of a Polyherbal Formulation for the Management of Diabetes},
journal = {Journal of Pharma Insights and Research},
year = {2026},
volume = {4},
number = {2},
pages = {016--023},
doi = {10.69613/a94s4w59}
}
EUVIMED